XT
REVB icon

XTX Topco’s Revelation Biosciences REVB Stock Holding History

XTX Topco’s Portfolio REVB Stock Details REVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$13.7K Buy
11,385
+8,555
+302% +$16.5K ﹤0.01% 3629
2025
Q4 		$9.05K Buy
+2,830
New +$12.4K ﹤0.01% 3193
2025
Q1 		– Sell
-260
Closed -$23K – 2988
2024
Q4 		$23K Buy
+260
New +$34.6K ﹤0.01% 2018

Other funds holding REVB

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return
HI
Harbour Investments Madison, Wisconsin $6.48B AUM 18.23% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return

XTX Topco's REVB Position: Q1 2026 in Review

XTX Topco increased its Revelation Biosciences (REVB) stake by 302% in Q1 2026, buying an estimated $16.5K and bringing the position to 11,385 shares worth $13.7K. The position accounts for ﹤0.01% of the portfolio, ranked #3629.

XTX Topco first reported a position in REVB in Q4 2024 and has held it in 3 quarters since. The position peaked at $23K in Q4 2024. 12 funds tracked by Wall St. Rank hold REVB as of Q1 2026.

  • XTX Topco held 11,385 shares of Revelation Biosciences worth $13.7K as of Q1 2026.
  • XTX Topco bought 8,555 Revelation Biosciences shares in Q1 2026, an estimated $16.5K.
  • Revelation Biosciences made up ﹤0.01% of XTX Topco's portfolio in Q1 2026, its #3629 holding.
  • XTX Topco first reported a position in Revelation Biosciences in Q4 2024 and has held it in 3 quarters since.
  • XTX Topco's Revelation Biosciences position peaked at $23K in Q4 2024.
  • 12 funds tracked by Wall St. Rank held Revelation Biosciences as of Q1 2026.

Based on XTX Topco's 13F filing for Q1 2026, filed 15 May 2026.